The U.S. Department of Health and Human Services unveils a new plan that could lower prescription drug costs, including a proposal to import FDA-approved drugs from other countries like Canada.
On the heels of Tuesday night’s Democratic debate where presidential hopefuls pitched plans to lower health care costs, the Trump administration moved to fulfill one of the president’s own pledges: lowering pharmaceutical drug costs.
According to HHS, the dual-pronged plan would establish a rule that would allow various entities, like states and pharmacists, to create proposals for the FDA. The FDA would then look at how “they would import certain drugs from Canada that are versions of FDA-approved drugs that are manufactured consistent with the FDA approval,” according to HHS.
HHS noted in its announcement that this part of the proposal could also potentially lower the price of medications for insulin and cancer, among others.“We’ve been very pleased to see Congress take significant interest on the issue of high drug prices and out-of-pocket costs,” he said.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump is exploring ways to let the US import cheaper prescription drugs from CanadaThe goal is lower prices and lower spending for American patients, a top Trump administration official said.
Read more »
Trump Administration Proposal Would Allow Prescription Drug Imports From CanadaThe Trump administration is proposing a trial plan to test whether imports of some less-expensive prescription drugs from Canada could rein in costs for consumers.
Read more »
Trump mocked over 9/11 claim with #LostTrumpHistory memes: 'Trump painted the Mona Lisa, invented cheeseburgers''In 2019, astronomer Donald Trump discovered that the Moon was a part of Mars. LostTrumpHistory,' George Conway tweeted.
Read more »
There's Now a 'Women For Trump' 2020 CoalitionLara Trump's Women for Trump coalition includes members Stacey Dash, Kaya Jones, Kathy Zhu, Diamond and Silk, and Alveda King.
Read more »